欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI?是时候来Springer出书了! |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Cancer Management and Research CANCER MANAG RES (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.3
53人评分
我要评分
声誉 6.9 影响力 5.0 速度 9.3 | |||||||||||||||||||||
期刊ISSN | 1179-1322 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 2.6 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:2.592 | |||||||||||||||||||||
2024-2025自引率 | 0.00%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 2.6 | |||||||||||||||||||||
JCI期刊引文指标 | 0.52 | |||||||||||||||||||||
h-index | 32 | |||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | https://www.dovepress.com/cancer-management-and-research-journal | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
期刊投稿网址 | https://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Management and Research的语言要求,还能让Cancer Management and Research编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Management and Research编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(1篇) 论文致谢(8篇) 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD2990; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:epidemiology、cancer、anticancer agents、cancer screening、palliative care 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||
出版商 | Dove Medical Press Ltd. | |||||||||||||||||||||
涉及的研究方向 | Medicine-Oncology | |||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | ||||||||||||||||||||||
出版年份 | 0 | |||||||||||||||||||||
年文章数 | 147点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 99.63% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 81.63% | |||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:3区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:预警等级:中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1179-1322%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 16 Weeks | |||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD2990; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Cancer Management and Research顺利发表。
快看看作者怎么说吧:服务好评(1篇) 论文致谢(8篇) 。 提交文稿 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | The Naples Prognostic Score Exerts a Significant Impact on the Prognosis of Patients Diagnosed with External Auditory Canal Carcinoma After Surgery Author: Xu, Xue-Lian; Cheng, Hao; Wu, Xin-Meng; Xu, Jin-Hong Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 985-996. DOI: 10.2147/CMAR.S527496 PubMed DOI |
2. | Expression and Diagnostic Value of Nrf2 and p62 in Cervical Squamous Cell Carcinoma and Intraepithelial Lesions Author: Wei, Wei; Hu, Xingyan; Han, Qing Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1005-1013. DOI: 10.2147/CMAR.S513226 PubMed DOI |
3. | Risk Factors and Prognostic Implications in Synchronous Breast-Thyroid Dual Primary Cancers: A Matched Case-Control Study Author: Li, Tao; Lu, Bin; Zhang, Yantao; Zhang, Peng; Qi, Jun; Sun, Yong Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 997-1004. DOI: 10.2147/CMAR.S505310 PubMed DOI |
4. | A Comprehensive Study of Part-Solid Lung Adenocarcinoma with Lymph Node Metastasis: Clinical, Pathological, and Radiological Perspectives Author: Zhao, Ziya; Gan, Hui; Fu, Bin-jie; Li, Wangjia; Lv, Fajin; Chu, Zhigang Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1015-1027. DOI: 10.2147/CMAR.S520781 PubMed DOI |
5. | Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients Author: Ni, Wenjie; Wang, Xiunan; Wang, Qin; Ge, Yongqing; Mu, Xiaofeng Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1047-1058. DOI: 10.2147/CMAR.S522807 PubMed DOI |
6. | Long Non-Coding RNA TPTEP1 Exerts Tumor Suppressive Functions via Sequestering miR-4295 to Regulate Growth Arrest and DNA Damage-Inducible 45α Expression in Acute Myeloid Leukemia Author: Liu, Xueni; Gui, Yonghui; Wang, Chao; Xia, Kang; Yang, Peng Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1059-1072. DOI: 10.2147/CMAR.S486875 PubMed DOI |
7. | Advances in Multimodal Imaging Techniques for Evaluating and Predicting the Efficacy of Immunotherapy for NSCLC Author: Liu, Jingyi; Xie, Mei; Shen, Jing; Yao, Jie; Lin, Xuwen; Bao, Xinyu; Zhang, Xin; Liang, Yiran; Yang, Yun; Jiang, Gege; Diao, Ximeng; Han, Wenya; Du, Hai; Xue, Xinying; Wu, Jianlin Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1073-1086. DOI: 10.2147/CMAR.S522136 PubMed DOI |
8. | Integrating Machine Learning Algorithms to Construct a Triaptosis-Related Prognostic Model in Melanoma Author: Xie, Jiaheng; Zhang, Min; Qi, Min Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1127-1141. DOI: 10.2147/CMAR.S525738 PubMed DOI |
9. | Associations Between Postoperative Symptom Clusters and Functional Status in Lung Cancer Patients: A Cross-Sectional Study Author: Liu, Yali; Lin, Siya; Bai, Meirong; Yi, Huochun Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1099-1111. DOI: 10.2147/CMAR.S507420 PubMed DOI |
10. | Jujuboside B Inhibits the Proliferation and Migration of Non-Small Cell Lung Cancer H1299 Cells Through Inhibiting PI3K/Akt and Wnt/β-Catenin Pathways Author: Chen, Mengzhu; Li, Jian; Hu, Shaodan; Wang, Yuhan; Wang, Keju; Wang, Tan Journal: CANCER MANAGEMENT AND RESEARCH. 2025; Vol. 17, Issue , pp. 1143-1153. DOI: 10.2147/CMAR.S526130 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室